Marker Therapeutics, Inc. — Director's Dealing 2007

Jul 3, 2007

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TAPIMMUNE INC (TPIM)
CIK: 0001094038
Period of Report: 2007-06-08

Reporting Person: WILSON GLYNN (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
OPTIONS	$0.25	2017-06-08	COMMON SHARES (200000)		Direct

Footnotes

F1: 400,000 options to acquire an equivalent number of common shares at $0.25 for 10 years granted; of which 200,000 do not vest until June 8, 2008.

F2: The Issuer's common stock underwent a reverse stock split on June 28, 2007 on a 2.5 old for one new share basis.